Stay updated on Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Locations section was reorganized under a centralized Locations block, with Georgia, New York, and Pennsylvania added as subsections and the separate state location blocks removed. The HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.SummaryDifference0.4%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe page displays a new revision label from v3.2.0 to v3.3.2, with no changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the administrative banner about potential data currency due to government funding lapse. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedThe study record now displays the Results First Posted date (2025-04-29) and updated Enrollment (Actual) and Primary Completion dates.SummaryDifference0.4%

- Check98 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference3%

- Check105 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.